Cargando…

Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay

BACKGROUND: Automated, high throughput assays are required to quantify the immune response after infection with or vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study on the Roche Elecsys(®) Anti-SARS-CoV-2 S (ACOV2S) assay provides insights on the assay desi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taffertshofer, Karin, Walter, Mirko, Mackeben, Peter, Kraemer, Julia, Potapov, Sergej, Jochum, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756759/ https://www.ncbi.nlm.nih.gov/pubmed/36532081 http://dx.doi.org/10.3389/fimmu.2022.1002576

Ejemplares similares

Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial
por: Jochum, Simon, et al.
Publicado: (2022)

Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial
por: Jochum, Simon, et al.
Publicado: (2021)

Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections
por: Grunau, Brian, et al.
Publicado: (2022)

Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis
por: Chan, Henry L Y, et al.
Publicado: (2022)

Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
por: Riester, Elena, et al.
Publicado: (2021)

Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
por: Muench, Peter, et al.
Publicado: (2020)

Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay
por: Tang, Nga-Yeung, et al.
Publicado: (2020)

Evaluation of the Elecsys SARS-CoV-2 antigen assay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
por: Ben Abdelhanin, Myriam, et al.
Publicado: (2021)

Analytical performance evaluation of the Elecsys® Cyclosporine and Elecsys® Tacrolimus assays on the cobas e411 analyzer
por: Sasano, Maki, et al.
Publicado: (2017)

Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma
por: Egger, Margot, et al.
Publicado: (2020)

Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs
por: Audigé, Annette, et al.
Publicado: (2021)

Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies
por: Aijaz, Javeria, et al.
Publicado: (2023)

Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers
por: Nakai, Miku, et al.
Publicado: (2023)

A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
por: Beyerl, Jessica, et al.
Publicado: (2021)

Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
por: Riester, Elena, et al.
Publicado: (2021)

Data on the Relationships of Signal-To-Cutoff Ratios of Elecsys HIV Antigen/Antibody and Elecsys Syphilis Assays to Subsequent Confirmatory Testing at an Academic Medical Center
por: Chopra, Saurav, et al.
Publicado: (2021)

Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment
por: Takei, Satomi, et al.
Publicado: (2022)

Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay
por: Vauloup-Fellous, C., et al.
Publicado: (2014)

Clinical Application Evaluation of Elecsys(®) HIV Duo Assay in Southwest China
por: Yang, Mei, et al.
Publicado: (2022)

Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
por: Ahmed, Mohamed I. M., et al.
Publicado: (2023)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

Evaluation of Elecsys Syphilis Assay for Routine and Blood Screening and Detection of Early Infection
por: Kremastinou, J., et al.
Publicado: (2016)

Derivation of cutoffs for the Elecsys(®) amyloid β (1–42) assay in Alzheimer's disease
por: Shaw, Leslie M., et al.
Publicado: (2018)

Diagnostic performance of the Elecsys SARS‐CoV‐2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single‐center evaluation
por: Mueller, Thomas, et al.
Publicado: (2021)

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
por: Kittel, Maximilian, et al.
Publicado: (2021)

Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications
por: Sulaeman, Hasan, et al.
Publicado: (2023)

A method to alleviate false-positive results of the Elecsys HIV combi PT assay
por: Lu, Xiaolan, et al.
Publicado: (2021)

Comparison of the Automated Fluorescent Immunoassay System With Roche Elecsys and Beckman Coulter Access 2 Assays for Anti-Müllerian Hormone Measurement
por: Han, Aera, et al.
Publicado: (2022)

AMHconverter: an online tool for converting results between the different anti-Müllerian hormone assays of Roche Elecsys(®), Beckman Access, and Kangrun
por: Xu, Huiyu, et al.
Publicado: (2023)

Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan
por: Laperche, Syria, et al.
Publicado: (2017)

Evaluation of Elecsys HTLV‐I/II assay in comparison with ARCHITECT rHTLV‐I/II assay with Korean samples
por: Yun, Seung Gyu, et al.
Publicado: (2019)

Analysis of SARS-CoV-2 antibodies from dried blood spot samples with the Roche Elecsys Immunochemistry method
por: Fontaine, Elizabeth, et al.
Publicado: (2021)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
por: Galipeau, Yannick, et al.
Publicado: (2020)

Paediatric reference intervals for plasma anti-Müllerian hormone: comparison of data from the Roche Elecsys assay and the Beckman Coulter Access assay using the same cohort of samples
por: Yates, Allen P, et al.
Publicado: (2019)

Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian Region
por: Lau, Chin Shern, et al.
Publicado: (2022)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Cortisol values during the standard-dose cosyntropin stimulation test: Personal experience with Elecsys cortisol II assay
por: Husni, Hasan, et al.
Publicado: (2022)

An Analysis of Predictive Sample-to-Cutoff Index for HIV Infection Confirmation Using Elecsys® HIV Combi PT Assay
por: Xia, Xiaohong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_smbi2ai2oqihtvkisfnsv9ek46